List of insiders holdings for MELINTA THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Vatera Healthcare Partners LLC VATERA HOLDINGS LLC Ferro Kevin Director 10% Owner | 2018-12-20 17:22:32 | 16,607,959 0 | 16,607,959 | Form 13D |
| Vatera Healthcare Partners LLC Vatera Capital Management LLC Ferro Kevin Director 10% Owner | 2019-08-12 21:35:56 | 12,780,731 0 | 12,780,731 | Form 13D |
| NEFF P SHERRILL Director | 2016-10-07 08:33:14 | 4976 3,527,154 | 3,532,130 | Form 4 |
| MEDICINES CO 10% Owner | 2018-01-11 17:07:09 | 3,313,702 0 | 3,313,702 | Form 3 |
| Quaker BioVentures II LP Quaker BioVentures Capital II L.P. 10% Owner | 2017-02-14 09:00:30 | 2,565,601 0 | 2,565,601 | Form 13G |
| Intersouth Associates VI LLC Intersouth Associates VII LLC INTERSOUTH PARTNERS VI LP INTERSOUTH PARTNERS VII L P Mumma Mitch Dougherty Dennis 10% Owner | 2017-02-13 16:52:16 | 2,359,239 0 | 2,359,239 | Form 13G |
| MORRIS I WISTAR III 10% Owner | 2012-08-21 16:07:19 | 770,668 1,515,300 | 2,285,968 | Form 4 |
| Aisling Capital II LP AISLING CAPITAL PARTNERS LLC AISLING CAPITAL PARTNERS LP SCHIFF ANDREW N Purcell Dennis J ELMS STEVE 10% Owner | 2016-03-09 17:09:59 | 1,239,668 0 | 1,239,668 | Form 13D |
| Fernandes Prabhavathi President and CEO | 2016-01-05 17:25:50 | 1,225,761 0 | 1,225,761 | Form 4 |
| Hahn Mark W EVP and CFO | 2017-02-27 17:28:58 | 529,630 0 | 529,630 | Form 4 |
| Moore David Chief Commercial Officer | 2017-02-27 17:35:34 | 422,523 0 | 422,523 | Form 4 |
| Oldach David W. Chief Medical Officer | 2017-02-27 17:32:05 | 381,052 0 | 381,052 | Form 4 |
| Bluth John D EVP of IR and Corp Comm | 2017-02-27 17:30:20 | 190,000 0 | 190,000 | Form 4 |
| Milligan Peter J Chief Financial Officer | 2019-05-20 20:21:28 | 150,000 0 | 150,000 | Form 4 |
| Wechsler Daniel Mark See Remarks | 2018-06-14 16:48:31 | 150,000 0 | 150,000 | Form 4 |
| Sanfilippo Jennifer A interim Chief Executive Office | 2019-09-13 14:59:39 | 126,200 0 | 126,200 | Form 3 |
| Cammarata Sue Chief Medical Officer | 2019-05-20 20:23:38 | 120,000 0 | 120,000 | Form 4 |
| Lococo Ryan Chief Operating Officer | 2019-10-25 12:53:33 | 105,620 0 | 105,620 | Form 3 |
| Kent Richard S Director | 2017-01-05 21:55:26 | 90,392 0 | 90,392 | Form 4 |
| DOUGHERTY MICHAEL R Director | 2017-01-05 21:56:30 | 87,000 0 | 87,000 | Form 4 |
| Temperato John Chief Commercial Officer | 2017-11-13 17:31:59 | 78,750 0 | 78,750 | Form 3 |
| Estrem Paul Chief Financial Officer | 2018-06-14 16:48:53 | 76,000 0 | 76,000 | Form 4 |
| Duffy Erin Chief Scientific Officer | 2018-06-14 16:51:17 | 38,000 0 | 38,000 | Form 4 |
| JOHNSON JOHN Chief Executive Officer | 2019-07-02 21:09:33 | 37,400 0 | 37,400 | Form 4 |
| Kong Garheng Director | 2018-06-14 16:53:24 | 34,100 0 | 34,100 | Form 4 |
| GONZALO CECILIA Director | 2018-06-14 16:55:43 | 34,100 0 | 34,100 | Form 4 |
| Galeota James JR Director | 2019-06-12 13:36:08 | 30,000 0 | 30,000 | Form 4 |
| Koestler Thomas P Director | 2019-06-12 13:36:27 | 30,000 0 | 30,000 | Form 4 |
| ZACCARDELLI DAVID Director | 2019-06-12 13:36:48 | 30,000 0 | 30,000 | Form 4 |
| GILL DAVID N Director | 2019-06-12 13:37:15 | 30,000 0 | 30,000 | Form 4 |
| DOWNEY BRUCE Director | 2019-06-12 13:37:37 | 30,000 0 | 30,000 | Form 4 |
| Ferro Kevin Director 10% Owner | 2019-06-12 13:37:56 | 30,000 0 | 30,000 | Form 4 |
| Blum Susan VP of Finance & CAO | 2019-10-25 12:53:01 | 29,957 0 | 29,957 | Form 3 |
| GOLDSTEIN DOV A MD Director | 2017-03-09 13:21:55 | 95 0 | 95 | Form 4 |